Biomarkers of drug-induced acute kidney injury: a regulatory perspective
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers of drug-induced acute kidney injury: a regulatory perspective
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 14, Issue 9, Pages 929-936
Publisher
Informa UK Limited
Online
2018-08-13
DOI
10.1080/17425255.2018.1511701
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical biomarker qualification
- (2017) John-Michael Sauer et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Revisiting biomarker discovery by plasma proteomics
- (2017) Philipp E Geyer et al. Molecular Systems Biology
- What evidence do we need for biomarker qualification?
- (2017) Chris Leptak et al. Science Translational Medicine
- High-throughput metabolomics enables biomarker discovery in prostate cancer
- (2017) Qun Liang et al. RSC Advances
- Recent developments in the detection and management of acute kidney injury
- (2016) James McCaffrey et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Early Predictors of Acute Kidney Injury: A Narrative Review
- (2016) Xiaoqin Liu et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Application of new acute kidney injury biomarkers in human randomized controlled trials
- (2016) Chirag R. Parikh et al. KIDNEY INTERNATIONAL
- Biomarcadores en la lesión renal aguda: ¿ paradigma o evidencia?
- (2016) Fernando Lombi et al. NEFROLOGIA
- Building a roadmap to biomarker qualification: challenges and opportunities
- (2015) Shashi G Amur et al. Biomarkers in Medicine
- Catalyzing the critical path initiative: FDA's progress in drug development activities
- (2015) A Parekh et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Biomarker Qualification: Toward a Multiple Stakeholder Framework for Biomarker Development, Regulatory Acceptance, and Utilization
- (2015) S Amur et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Biomarkers of delayed graft function as a form of acute kidney injury in kidney transplantation
- (2015) Jolanta Malyszko et al. Scientific Reports
- Biomarkers of AKI: A Review of Mechanistic Relevance and Potential Therapeutic Implications
- (2014) J. L. Alge et al. Clinical Journal of the American Society of Nephrology
- Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers
- (2014) Kui Wang et al. Expert Review of Proteomics
- The Biomarkers Consortium
- (2014) David Wholley NATURE REVIEWS DRUG DISCOVERY
- Biomarkers for Acute Kidney Injury: Where Are We Today? Where Should We Go?
- (2013) J. C. Lieske et al. CLINICAL CHEMISTRY
- Evaluation of 32 urine biomarkers to predict the progression of acute kidney injury after cardiac surgery
- (2013) John M. Arthur et al. KIDNEY INTERNATIONAL
- Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference
- (2013) Patrick T. Murray et al. KIDNEY INTERNATIONAL
- Safety pharmacology — Current and emerging concepts
- (2013) Junnat Hamdam et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Detection and management of nephrotoxicity during drug development
- (2012) Dr Mahmoud Loghman-Adham et al. Expert Opinion On Drug Safety
- Qualified kidney biomarkers and their potential significance in drug safety evaluation and prediction
- (2012) Hong-Guang Xie et al. PHARMACOLOGY & THERAPEUTICS
- Preclinical perspective of urinary biomarkers for the detection of nephrotoxicity: what we know and what we need to know
- (2011) Tobias Christian Fuchs et al. Biomarkers in Medicine
- Biomarkers for the early detection of acute kidney injury
- (2011) Prasad Devarajan CURRENT OPINION IN PEDIATRICS
- Evaluation of Drugs With Specific Organ Toxicities in Organ-Specific Cell Lines
- (2011) Zhiwu Lin et al. TOXICOLOGICAL SCIENCES
- Evolution of biomarker qualification at the health authorities
- (2010) Federico Goodsaid et al. NATURE BIOTECHNOLOGY
- Research at the interface of industry, academia and regulatory science
- (2010) William B Mattes et al. NATURE BIOTECHNOLOGY
- A roadmap for biomarker qualification
- (2010) David G Warnock et al. NATURE BIOTECHNOLOGY
- Creatinine as the gold standard for kidney injury biomarker studies?
- (2009) S. S. Waikar et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The FDA Critical Path Initiative and Its Influence on New Drug Development
- (2008) Janet Woodcock et al. Annual Review of Medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now